Logo

Aura Biosciences, Inc.

AURA

Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develops AU-011 in additional ocular oncology indications, i… read more

Healthcare

Biotechnology

4 years

USD

Exclusive to Premium users

Price

per share adjusted in USD

$7.04

Price

+0.50%

$0.03

Market Cap

$451.966m

Small

Price/Earnings

-

Premium

3y Avg

Premium

5y Avg

Financial Reports

Key metrics over the past few years and other important metrics. Amounts in USD.

-

EBITDA Margin

-

Net Profit Margin

-

Free Cash Flow Margin

-

EBITDA Margin

-

Net Profit Margin

-

Free Cash Flow Margin
Revenue

$0.00

-

1y CAGR

-

3y CAGR

-

5y CAGR
Earnings

-$112.393m

-5.8%

1y CAGR

-13.9%

3y CAGR

-17.9%

5y CAGR
EPS

-$1.77

-0.6%

1y CAGR

+2.7%

3y CAGR

+2.4%

5y CAGR
Book Value

$107.247m

$137.677m

Assets

$30.430m

Liabilities

$16.991m

Debt
Debt to Assets

12.3%

-0.1x

Debt to EBITDA
Free Cash Flow

-$91.642m

-7.6%

1y CAGR

-12.7%

3y CAGR

-13.5%

5y CAGR
No items found.
Press Releases
Statements and updates from the company
↑ TopSummaryPriceFinancialsPress Releases